Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
Bydgoszcz, Poland
Cancer treatment center in Bydgoszcz
ul. dr I. Romanowska, 85-796 Bydgoszcz
About Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Janssen Research & Development, LLC
9
Gilead Sciences
3
Bayer
2
Merck Sharp & Dohme LLC
2
Prof. Franciszek Lukaszczyk Memorial Oncology Center
2
Amgen
1
Celgene
1
Daiichi Sankyo, Inc.
1
Galera Therapeutics, Inc.
1
Genentech, Inc.
1
Clinical Trials at Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
During the past decade, Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 15 clinical trials were completed, i.e. on
average, 46.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 8 clinical trials were completed. i.e. 47.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
2009-06-29
2015-09-09
Completed
921
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
2011-12-01
2015-02-01
Terminated
266
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
2014-11-12
2017-03-13
Completed
334
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Janssen Research & Development, LLC" with 9 trials
sponsored, "Gilead Sciences" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Merck Sharp & Dohme LLC"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
According to Clinical.Site data, the most researched conditions in "Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy" are
"Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Colorectal Cancer" (2 trials), "Gastric Cancer" (2 trials) and "Glioblastoma Multiforme" (2 trials). Many other conditions were trialed in "Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
Most popular intervention types in "Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy" are "Drug" (35 trials), "Other" (4 trials), "Radiation" (4 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Carboplatin" (5 trials), "Cisplatin" (5 trials), "Docetaxel" (5 trials) and "Pembrolizumab" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
The vast majority of trials in "Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy" are
32 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.
Clinical Trials Status at Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
Currently, there are NaN active trials in "Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy".
undefined are not yet recruiting,
16 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy
Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy has several departments that took part in Clinical trials: "Centrum Onkologii w Bydgoszczy; Oddzial Kliniczny Onkologii" - 3 trials, "Centrum Onkologii im. Prof. Franciszka Łukaszczyka; Ambulatorium Chemioterapii" - 3 trials
Departments List